{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:34:47Z","timestamp":1791862487790,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Epworth Medical Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-025-09289-5","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T08:45:58Z","timestamp":1765874758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of a core outcome set for the assessment of spasticity in adults: a study protocol"],"prefix":"10.1186","volume":"26","author":[{"given":"Bridget","family":"Hill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Ashford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Barden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5416-2118","authenticated-orcid":false,"given":"Megan","family":"Banky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"issue":"5","key":"9289_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1191\/1352458504ms1085oa","volume":"10","author":"MA Rizzo","year":"2004","unstructured":"Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler J. 2004;10(5):589\u201395.","journal-title":"Mult Scler J"},{"issue":"10","key":"9289_CR2","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3109\/02699052.2013.804202","volume":"27","author":"A Thibaut","year":"2013","unstructured":"Thibaut A, Chatelle C, Ziegler E, Bruno M, Laureys S, Gosseries O. Spasticity after stroke: physiology, assessment and treatment. Brain Inj. 2013;27(10):1093\u2013105.","journal-title":"Brain Inj"},{"issue":"4","key":"9289_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.apmr.2008.10.013","volume":"90","author":"GP Williams","year":"2009","unstructured":"Williams GP, Morris ME, Schache A, McCrory PR. Incidence of gait abnormalities after traumatic brain injury. Arch Phys Med Rehabil. 2009;90(4):587\u201393.","journal-title":"Arch Phys Med Rehabil"},{"key":"9289_CR4","doi-asserted-by":"publisher","first-page":"8160","DOI":"10.12659\/MSM.911296","volume":"24","author":"X Yan","year":"2018","unstructured":"Yan X, Lan J, Liu Y, Miao J. Efficacy and safety of botulinum toxin type A in spasticity caused by spinal cord injury: a randomized, controlled trial. Med Sci Monit. 2018;24:8160.","journal-title":"Med Sci Monit"},{"issue":"2","key":"9289_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/jnnp.69.2.217","volume":"69","author":"BB Bhakta","year":"2000","unstructured":"Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol Neurosurg Psychiatry. 2000;69(2):217\u201321.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"9289_CR6","doi-asserted-by":"publisher","first-page":"714","DOI":"10.2340\/16501977-0423","volume":"41","author":"B Lindstr\u00f6m","year":"2009","unstructured":"Lindstr\u00f6m B, R\u00f6ding J, Sundelin G. Positive attitudes and preserved high level of motor performance are important factors for return to work in younger persons after stroke: a national survey. J Rehabil Med. 2009;41(9):714\u20138.","journal-title":"J Rehabil Med"},{"issue":"4","key":"9289_CR7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/09638288.2020.1769207","volume":"44","author":"G Williams","year":"2022","unstructured":"Williams G, Singer BJ, Ashford S, Hoare B, Hastings-Ison T, Fheodoroff K, et al. A synthesis and appraisal of clinical practice guidelines, consensus statements and Cochrane systematic reviews for the management of focal spasticity in adults and children. Disabil Rehabil. 2022;44(4):509\u201319.","journal-title":"Disabil Rehabil"},{"issue":"1\u20132","key":"9289_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/09638280400014592","volume":"27","author":"JH Burridge","year":"2005","unstructured":"Burridge JH, Wood DE, Hermens HJ, Voerman GE, Johnson GR, van Wijck F, et al. Theoretical and methodological considerations in the measurement of spasticity. Disabil Rehabil. 2005;27(1\u20132):69\u201380.","journal-title":"Disabil Rehabil"},{"key":"9289_CR9","doi-asserted-by":"crossref","unstructured":"Pandyan AD, Gregoric M, Barnes MP, Wood D, Wijck F, Buridge J. Spasticity: clinical perception, neurological realities and meaningful measurement. Disabil Rehabil. 2005;27:2\u20136.","DOI":"10.1080\/09638280400014576"},{"key":"9289_CR10","unstructured":"Ashford S, Turner-Stokes L, Allison R, Duke L, Moore P, Bavikatte G, et al. Spasticity in adults: management using botulinum toxin. National guidelines. Royal College of Physicians. 2018."},{"issue":"Suppl 2","key":"9289_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1468-1331.2010.03128.x","volume":"17","author":"J Olver","year":"2010","unstructured":"Olver J, Esquenazi A, Fung VS, Singer BJ, Ward AB. Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement. Eur J Neurol. 2010;17(Suppl 2):57\u201373.","journal-title":"Eur J Neurol"},{"issue":"1","key":"9289_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-017-0670-9","volume":"7","author":"AD Gupta","year":"2018","unstructured":"Gupta AD, Chu WH, Howell S, Chakraborty S, Koblar S, Visvanathan R, et al. A systematic review: efficacy of botulinum toxin in walking and quality of life in post-stroke lower limb spasticity. Syst Rev. 2018;7(1):1\u20139.","journal-title":"Syst Rev"},{"issue":"26","key":"9289_CR13","doi-asserted-by":"publisher","first-page":"8515","DOI":"10.1080\/09638288.2021.2011437","volume":"44","author":"E Sutherland","year":"2022","unstructured":"Sutherland E, Hill B, Singer BJ, Ashford S, Hoare B, Hastings-Ison T, et al. Do randomised controlled trials evaluating functional outcomes following botulinum neurotoxin-A align with focal spasticity guidelines? A systematic review. Disabil Rehabil. 2022;44(26):8515\u201323.","journal-title":"Disabil Rehabil"},{"issue":"4","key":"9289_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/10833196.2022.2059942","volume":"27","author":"SM Aloraini","year":"2022","unstructured":"Aloraini SM, Alyosuf EY, Aloraini LI, Aldaihan MM. Assessment of spasticity: an overview of systematic reviews. Phys Ther Rev. 2022;27(4):290\u2013303.","journal-title":"Phys Ther Rev"},{"issue":"25","key":"9289_CR15","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.3109\/09638288.2015.1014933","volume":"37","author":"SM Aloraini","year":"2015","unstructured":"Aloraini SM, G\u00e4verth J, Yeung E, MacKay-Lyons M. Assessment of spasticity after stroke using clinical measures: a systematic review. Disabil Rehabil. 2015;37(25):2313\u201323.","journal-title":"Disabil Rehabil"},{"issue":"1\u20132","key":"9289_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/09638280400014634","volume":"27","author":"T Platz","year":"2005","unstructured":"Platz T, Eickhof C, Nuyens G, Vuadens P. Clinical scales for the assessment of spasticity, associated phenomena, and function: a systematic review of the literature. Disabil Rehabil. 2005;27(1\u20132):7\u201318.","journal-title":"Disabil Rehabil"},{"issue":"1","key":"9289_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s13063-016-1555-2","volume":"17","author":"CAC Prinsen","year":"2016","unstructured":"Prinsen CAC, Vohra S, Rose MR, Boers M, Tugwell P, Clarke M, et al. How to select outcome measurement instruments for outcomes included in a \u201ccore outcome set\u201d \u2013 a practical guideline. Trials. 2016;17(1):449.","journal-title":"Trials"},{"issue":"Suppl 3","key":"9289_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13063-017-1978-4","volume":"18","author":"PR Williamson","year":"2017","unstructured":"Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, et al. The COMET handbook: version 1.0. Trials. 2017;18(Suppl 3):280.","journal-title":"Trials"},{"key":"9289_CR19","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ"},{"issue":"11","key":"9289_CR20","doi-asserted-by":"publisher","first-page":"e1002447","DOI":"10.1371\/journal.pmed.1002447","volume":"14","author":"JJ Kirkham","year":"2017","unstructured":"Kirkham JJ, Davis K, Altman DG, Blazeby JM, Clarke M, Tunis S, et al. Core Outcome Set-STAndards for Development: the COS-STAD recommendations. PLoS Med. 2017;14(11):e1002447.","journal-title":"PLoS Med"},{"key":"9289_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jclinepi.2023.03.022","volume":"158","author":"S Dodd","year":"2023","unstructured":"Dodd S, Gorst SL, Young A, Lucas SW, Williamson PR. Patient participation impacts outcome domain selection in core outcome sets for research: an updated systematic review. J Clin Epidemiol. 2023;158:127\u201333.","journal-title":"J Clin Epidemiol"},{"key":"9289_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2288-5-37","volume":"5","author":"RB Akins","year":"2005","unstructured":"Akins RB, Tolson H, Cole BR. Stability of response characteristics of a Delphi panel: application of bootstrap data expansion. BMC Med Res Methodol. 2005;5:37.","journal-title":"BMC Med Res Methodol"},{"key":"9289_CR23","doi-asserted-by":"publisher","first-page":"111485","DOI":"10.1016\/j.jclinepi.2024.111485","volume":"174","author":"AM Manyara","year":"2024","unstructured":"Manyara AM, Purvis A, Ciani O, Collins GS, Taylor RS. Sample size in multistakeholder Delphi surveys: at what minimum sample size do replicability of results stabilize? J Clin Epidemiol. 2024;174:111485.","journal-title":"J Clin Epidemiol"},{"key":"9289_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s13063-015-0913-9","volume":"16","author":"JJ Kirkham","year":"2015","unstructured":"Kirkham JJ, Gorst S, Altman DG, Blazeby J, Clarke M, Devane D, et al. COS-STAR: a reporting guideline for studies developing core outcome sets (protocol). Trials. 2015;16:373.","journal-title":"Trials"},{"issue":"5","key":"9289_CR25","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s11136-018-1798-3","volume":"27","author":"CAC Prinsen","year":"2018","unstructured":"Prinsen CAC, Mokkink LB, Bouter LM, Alonso J, Patrick DL, de Vet HCW, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1147\u201357.","journal-title":"Qual Life Res"},{"issue":"5","key":"9289_CR26","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s11136-017-1765-4","volume":"27","author":"LB Mokkink","year":"2018","unstructured":"Mokkink LB, de Vet HCW, Prinsen CAC, Patrick DL, Alonso J, Bouter LM, et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1171\u20139.","journal-title":"Qual Life Res"},{"issue":"2","key":"9289_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.apmr.2011.09.015","volume":"93","author":"LA Connell","year":"2012","unstructured":"Connell LA, Tyson SF. Clinical reality of measuring upper-limb ability in neurologic conditions: a systematic review. Arch Phys Med Rehabil. 2012;93(2):221\u20138.","journal-title":"Arch Phys Med Rehabil"},{"issue":"1","key":"9289_CR28","doi-asserted-by":"publisher","first-page":"e1004326","DOI":"10.1371\/journal.pmed.1004326","volume":"21","author":"WT Gattrell","year":"2024","unstructured":"Gattrell WT, Logullo P, van Zuuren EJ, Price A, Hughes EL, Blazey P, et al. ACCORD (ACcurate COnsensus Reporting Document): a reporting guideline for consensus methods in biomedicine developed via a modified Delphi. PLoS Med. 2024;21(1):e1004326.","journal-title":"PLoS Med"}],"updated-by":[{"DOI":"10.1186\/s13063-026-09431-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000}}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09289-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09289-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09289-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:13:23Z","timestamp":1768342403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-025-09289-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9289"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09289-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13063-026-09431-x","URL":"https:\/\/doi.org\/10.1186\/s13063-026-09431-x","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study obtained ethical approval from The University of Melbourne HREC committee, study number 2025-31748-64667-3. Any amendments will be formally submitted through the ethics committee. Informed consent will be obtained from all study participants. Written informed consent will be obtained from all participants involved in phase 1 by a member of the research team. Digital informed consent will be obtained from all participants involved in phases 2 and 4 on completion of the first survey round. Participants will not be granted access to proceed to the Delphi until consent has been obtained. No consent is required for phase 3.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"567"}}